Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

August 16, 2019

Protein Treatment, GRF6019, Seen to Help Maintain Cognition in Alzheimer’s Patients in Phase 2 Trial

News

Alkahest’s experimental blood-derived protein GRF6019 helps maintain cognition and function in mild to moderate Alzheimer’s disease patients, results of a six-month Phase 2 clinical trial show. “These top-line results indicate ... Read more

August 14, 2019August 14, 2019

Blood Markers May ID People Most Likely to Gain Cognitively with Aerobic Exercise, Study Reports

News

Blood levels of certain molecules— metabolites and amino acids — may help to identify people with Alzheimer’s disease who are more likely to improve their cognitive skills in response to aerobic ... Read more

August 12, 2019August 12, 2019

AC Immune’s Anti-Tau Vaccine ACI-35.030 to Be Tested in Phase 1b/2a Trial

News

AC Immune is launching a Phase 1b/2a clinical trial to evaluate an investigational anti-tau vaccine called ACI-35.030 as a potential disease-modifying treatment for Alzheimer’s disease and other disorders characterized by ... Read more

August 7, 2019August 7, 2019

AZTherapies Completes Enrollment for ALZT-OP1 Trial for Early Alzheimer’s

News

AZTherapies has completed enrollment for its Phase 3 COGNITE trial, testing the safety and efficacy of its investigational ALZT-OP1 for the treatment of early Alzheimer’s disease (AD). A total ... Read more

August 5, 2019August 5, 2019

Chemical Compound Can Restore Neural Function in Familial Alzheimer’s, Study Finds

News

A mutation in a gene linked to familial Alzheimer’s disease promotes the disease by reducing the points of contact between nerve cells and impairing neuronal communication, a study ... Read more

July 29, 2019July 29, 2019

Carriers of CHRFAM7A gene Less Responsive to Cholinesterase Inhibitors, Study Suggests

News

Alzheimer’s disease patients carrying a gene found only in humans, called CHRFAM7A, are less responsive to cholinesterase inhibitors, a new study reports. These findings may explain why some therapeutic ... Read more

July 26, 2019July 26, 2019

Samus Therapeutics Launches Phase 1 Trial of Tau-targeting Therapy

News

Following the approval of its investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA), Samus Therapeutics is launching a Phase 1 trial in the United ... Read more

July 19, 2019July 19, 2019

Healthy Lifestyle Choices May Lower Risk of Cognitive Decline and Alzheimer’s Dementia, Research Shows

News

Healthy lifestyle choices — maintaining an active mind, a nutritious diet, and regular exercise — may help protect against cognitive decline and dementia, new research shows. Moreover, cigarette smoking ... Read more

July 17, 2019July 17, 2019

Therapeutic Inhibitors of LIMK1 May Help Halt Cognitive Decline in Alzheimer’s, Study Suggests

News

Inhibition of a protein called LIMK1 may help prevent the loss of dendritic spines — the connections between neurons in the brain — triggered by the build-up of beta-amyloid ... Read more

July 1, 2019July 1, 2019

Women Carrying ApoE4 Gene More Susceptible Than Men to Toxic Tau Clumps in Brain, Study Suggests

News

Women who are carriers of the ApoE4 gene — a major genetic risk factor for the development of a late-onset form of Alzheimer’s disease, are more susceptible than men ... Read more

Pin It on Pinterest